Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868369 · ClinicalTrials.gov registry record · NA
The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy
A NA study of Hip Pain Chronic, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT05868369: Recruiting NA study of Hip Pain Chronic, sponsored by Cedars-Sinai Medical Center.
NCT05868369 is a NA study of Hip Pain Chronic that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05868369, a NA study of Hip Pain Chronic, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
1. The purpose of the research is to assess the efficacy of postoperative immersive virtual reality (iVR) compared to a standard multimodal pain regimen including opioids and a local block on acute postoperative pain management following hip arthroscopy 2. The primary research procedures are medical record review for demographic information, head-mounted immersive virtual reality experience in PACU, and pre-operative and post-operative surveys 3. The study will enroll adult patients of all ages undergoing elective hip arthroscopy procedures for any diagnosis
Primary Outcome
subjects rate their pain from 0-10, 0 being the least and 10 being the worst.
Conditions Studied
Interventions
- DEVICE iVR Group
- DRUG Standard pain management regimen
Study Locations (2)
California
- Kerlan Jobe - Los Angeles
- Kerlan Jobe - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2028-08 |
| Phase | NA |
What NCT05868369 shows while recruiting
NCT05868369 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Hip Pain Chronic appearing as the primary indexed condition, and to 2 interventions - of which iVR Group is the first listed.
NCT05868369 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05868369 about?
NCT05868369 is a clinical study titled "The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy". 1. The purpose of the research is to assess the efficacy of postoperative immersive virtual reality (iVR) compared to a standard multimodal pain regimen including opioids and a local block on acute postoperative pain management following hip arthroscopy 2. The primary research procedures are medical...
What is the current status of trial NCT05868369?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-11-01. Estimated completion is 2028-08.
What conditions does trial NCT05868369 study?
This clinical trial studies the following conditions: Hip Pain Chronic.
What interventions are being tested in trial NCT05868369?
The interventions under investigation include: iVR Group (DEVICE), Standard pain management regimen (DRUG).
Who is sponsoring clinical trial NCT05868369?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05868369 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Pain Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05868369's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI